ARTICLE | Distillery Therapeutics
Targeting hexokinase 2 to enhance intratumoral drug delivery
December 3, 2021 5:34 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Non-small cell lung cancer (NSCLC); hepatocellular carcinoma...
BCIQ Company Profiles
BCIQ Target Profiles